Cardiac amyloidosis: the need for early diagnosis von Oerlemans, M. I. F. J., Rutten, K. H. G., Minnema, M. C., Raymakers, R. A. P., Asselbergs, F. W., de Jonge, N.

Volltext

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial von Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, Le, Salwender, H J, Sonneveld, P

Volltext

Neutrophilic leukemoid reaction with extended fibrosis due to ectopic G-CSF production von Andriessen, M.V.E., Raymakers, R.

Volltext

'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma von Rutten, K H G, Raymakers, R A P, Minnema, M C

Volltext

Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis von Slot, S, Smits, K, van de Donk, N W C J, Witte, B I, Raymakers, R, Janssen, J J W M, Broers, A E C, te Boekhorst, P A W, Zweegman, S

Volltext

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progre... von Lokhorst, Henk M, van der Holt, Bronno, Cornelissen, Jan J, Kersten, Marie José, van Oers, Marinus, Raymakers, Reinier, Minnema, Monique C, Zweegman, Sonja, Bos, Gerard, Schaap, Nicolaas, Wittebol, Shulamiet, de Weerdt, Okke, Ammerlaan, Rianne, Sonneveld, Pieter

Volltext

In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review von Oostvogels, R, Uniken Venema, S M, de Witte, M, Raymakers, R, Kuball, J, Kröger, N, Minnema, M C

Volltext

P644: THE LIFE EXPECTANCY OF PATIENTS WITH HAIRY CELL LEUKEMIA VERGES UPON THE LIFE EXPECTANCY OF THE GENERAL POPULATION: A POPULATION‐BASED STUDY IN THE NETHERLANDS von Dinmohamed, A., Maas, C., Visser, O., Doorduijn, J., Mous, R., Raymakers, R., Kater, A., Posthuma, W.

Volltext

Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38− cells von de Grouw, E P L M, Raaijmakers, M H G P, Boezeman, J B, van der Reijden, B A, van de Locht, L T F, de Witte, T J M, Jansen, J H, Raymakers, R A P

Volltext

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma von VAN DE DONK, N. W. C. J, KRÖGER, N, AYUK, F. A, VAN OERS, M. H. J, NAGLER, A, VERDONCK, L. F, LOKHORST, H. M, HEGENBART, U, CORRADINI, P, SAN MIGUEL, J. F, GOLDSCHMIDT, H, PEREZ-SIMON, J. A, ZIJIMANS, M, RAYMAKERS, R. A, MONTEFUSCO, V

Volltext

Exclusion of ABCB8 and ABCB10 as cancer candidate genes in acute myeloid leukemia von Tang, L, Bergevoet, S M, Franssen, L E, de Witte, T, Jansen, J H, Raymakers, R A P, van der Reijden, B A

Volltext

Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival von LEVENGA, H, LEVISON-KEATING, S, SCHATTENBERG, A. V, DOLSTRA, H, SCHAAP, N, RAYMAKERS, R. A

Volltext

Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions von Hoevenaren, A, van Vulpen, L F D, Levenga, H, Minnema, M C, Raymakers, R

Volltext

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients von Oostvogels, Rimke, Jak, Margot, Raymakers, Reinier, Mous, Rogier, Minnema, Monique C.

Volltext

Outbreak of respiratory distress resembling influenza caused by Actinobacillus pleuropneumoniae in pigs von Tobias, T. J., Raymakers, R. J. M. L., van Nes, A., van Leengoed, L. A. M. G.

Volltext

X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise von Donker, A E, Raymakers, R A, Nieuwenhuis, H K, Coenen, M J H, Janssen, M C, MacKenzie, M A, Brons, P P T, Swinkels, D W

Volltext

Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis von SWINKELS, D. W, JOMA, A. T. M, RAYMAKERS, R. A. P

Volltext

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome von Minnema, M C, van de Donk, N W C J, Zweegman, S, Hegenbart, U, Schonland, S, Raymakers, R, Zijlmans, J M J M, Kersten, M J, Bos, G M J, Lokhorst, H M

Volltext

Thalidomide and lenalidomide in primary myelofibrosis von Holle, N, de Witte, T, Mandigers, C, Schaap, N, Raymakers, R

Volltext

Adverse Event (AE) Management With Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) in the STRATUS(TM) Trial: A Phase 3b Study Evaluating Safety and Efficacy in Patients (Pts) W... von Cavo, M, Dimopoulos, M.A, Moreau, P, Palumbo, A, Corradini, P, Weisel, K, Ocio, E, Doyen, C, Anttila, P, Raymakers, R, San Miguel, J, Knop, S, Yu, X, Milller, N, Herring, J, Slaughter, A, Biyukov, T, Peluso, T, Sternas, L, Zaki, M, Delforge, M

Volltext